Topic Archives: Money Map

Comments

No comments.

Examining the “One Device to End All Disease… And It Costs Less Than $50” ad from Radical Technology Profits

That headline might look a little familiar to longtime Gumshoe readers… that’s because Michael Robinson had a very similar ad back in 2013 (and again in 2015) touting MEMS as a “device to end all disease” … … so, is the ad still about the same stock? Let’s look and see. Here’s how the pitch […]

Zenith Trading Circle

Trading service that recommends out-of-the-money put options to profit from companies with weak financials, with “carbon trades” that are essentially rolling those same put option trades forward when they expire and hoping to profit several times from a stock in persistent decline. Launched by Michael Lewitt in September 2016, he was replaced by Shah Gilani […]

Two new Liquid Biopsy teases: “Free Shares” and “End the 8 Deadliest Diseases”

Today we’ve got a two-fer — two different big publishers are teasing different “liquid biopsy” stocks, and I’m no expert on the technology or the prospects for this diagnostic “trend” that we’ve been hearing more about… so I’ll just sift the clues, identify the companies, and let you chatter about their merits amongst yourselves. The […]

“New Gas Molecule That Burns Hotter than the Sun” — Dr. Kent Moors says “there’s never been a moneymaking situation quite like this in the entire history of energy!”

I haven’t rushed in to cover this teaser pitch over the past few days, partly because I’ve already written about so many of the overhyped Money Map Press ads recently and partly because Gumshoe readers have already discussed it a little bit (and identified the stock) … … but a lot of you have been […]

“Help Destroy China’s ‘Internet Army'”

“Yesterday, I sent you an urgent briefing regarding China’s dangerous “Internet Army.” This situation is already moving fast. “The small tech company critical to crushing China’s attacks just won another contract for an undisclosed “data center”… its third multimillion-dollar contract in less than a month. “This is quickly turning into exactly the kind of win-win […]

“One tiny drug company … we think is the ‘surest thing’ we’ve ever found…” (Money Map Passport Club Teaser)

“Why I’m Ready to Place a $2,450 “Bet” on Your Behalf… “Given what we’ve learned about one tiny drug company – and the documented 82% success rate within the category of drug it’s developed – we think this is the “surest thing” we’ve ever found… “How this ‘wager’ could make you thousands of dollars (or […]

“‘The Retirement Stock’ … on the verge of gaining FDA approval for the only ‘female Viagra'”

This is really disappointing. All this time I’ve been under the impression that your friendly neighborhood Stock Gumshoe and his terrifically handsome likeness were all the “female Viagra” the world needed … but apparently some pharmaceutical companies disagree, and have been trying to develop a drug along those lines. At least, that’s the pitch from […]

“The new energy boom that’s predicted to be 15,566% bigger than oil… and it could QUADRUPLE your money in the next 8 to 12 months… ” (Dr. Kent Moors)

Dr. Kent Moors, who teaches political science at Duquesne and is an expert consultant on oil and gas topics, launched a newsletter with one of the many hype-crazy Agora-related publishers last year (Money Map Press, if you’re keeping track, itself a spinoff of Oxford Club if I’m keeping the spaghetti strands in order). In fact, […]

This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.